CORVEL CORP (CRVL) Fundamental Analysis & Valuation

NASDAQ:CRVL • US2210061097

Current stock price

57.66 USD
-0.46 (-0.79%)
Last:

This CRVL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. CRVL Profitability Analysis

1.1 Basic Checks

  • In the past year CRVL was profitable.
  • CRVL had a positive operating cash flow in the past year.
  • In the past 5 years CRVL has always been profitable.
  • Each year in the past 5 years CRVL had a positive operating cash flow.
CRVL Yearly Net Income VS EBIT VS OCF VS FCFCRVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1.2 Ratios

  • CRVL has a Return On Assets of 16.40%. This is amongst the best in the industry. CRVL outperforms 99.00% of its industry peers.
  • With an excellent Return On Equity value of 28.14%, CRVL belongs to the best of the industry, outperforming 94.00% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 27.56%, CRVL belongs to the best of the industry, outperforming 98.00% of the companies in the same industry.
  • CRVL had an Average Return On Invested Capital over the past 3 years of 28.60%. This is significantly above the industry average of 8.40%.
Industry RankSector Rank
ROA 16.4%
ROE 28.14%
ROIC 27.56%
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
CRVL Yearly ROA, ROE, ROICCRVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • CRVL's Profit Margin of 11.23% is amongst the best of the industry. CRVL outperforms 98.00% of its industry peers.
  • CRVL's Profit Margin has improved in the last couple of years.
  • CRVL has a Operating Margin of 14.52%. This is amongst the best in the industry. CRVL outperforms 90.00% of its industry peers.
  • CRVL's Operating Margin has improved in the last couple of years.
  • CRVL has a Gross Margin (24.22%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CRVL has grown nicely.
Industry RankSector Rank
OM 14.52%
PM (TTM) 11.23%
GM 24.22%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
CRVL Yearly Profit, Operating, Gross MarginsCRVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CRVL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRVL is creating value.
  • The number of shares outstanding for CRVL remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CRVL has less shares outstanding
  • CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRVL Yearly Shares OutstandingCRVL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CRVL Yearly Total Debt VS Total AssetsCRVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 11.32 indicates that CRVL is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of CRVL (11.32) is better than 96.00% of its industry peers.
  • There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.32
ROIC/WACC3.08
WACC8.95%
CRVL Yearly LT Debt VS Equity VS FCFCRVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.85 indicates that CRVL should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.85, CRVL is in the better half of the industry, outperforming 76.00% of the companies in the same industry.
  • CRVL has a Quick Ratio of 1.85. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
  • CRVL has a better Quick ratio (1.85) than 78.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
CRVL Yearly Current Assets VS Current LiabilitesCRVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CRVL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.73% over the past year.
  • The Earnings Per Share has been growing by 16.86% on average over the past years. This is quite good.
  • CRVL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.06%.
  • Measured over the past years, CRVL shows a quite strong growth in Revenue. The Revenue has been growing by 8.62% on average per year.
EPS 1Y (TTM)21.73%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%2.17%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%3.36%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRVL Yearly Revenue VS EstimatesCRVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

Find the best growth stocksShow best growing peers

2

4. CRVL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 28.26 indicates a quite expensive valuation of CRVL.
  • CRVL's Price/Earnings ratio is in line with the industry average.
  • CRVL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.26
Fwd PE N/A
CRVL Price Earnings VS Forward Price EarningsCRVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRVL is on the same level as its industry peers.
  • CRVL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 28.29
EV/EBITDA 16.34
CRVL Per share dataCRVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The excellent profitability rating of CRVL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.68
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CRVL Dividend Analysis

5.1 Amount

  • No dividends for CRVL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CRVL Fundamentals: All Metrics, Ratios and Statistics

CORVEL CORP

NASDAQ:CRVL (4/28/2026, 2:35:19 PM)

57.66

-0.46 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03
Earnings (Next)05-20
Inst Owners53.94%
Inst Owner Change0.39%
Ins Owners7.05%
Ins Owner Change-0.14%
Market Cap2.95B
Revenue(TTM)941.49M
Net Income(TTM)105.73M
Analysts0
Price TargetN/A
Short Float %3.36%
Short Ratio3.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.26
Fwd PE N/A
P/S 3.13
P/FCF 28.29
P/OCF 19.78
P/B 7.85
P/tB 8.71
EV/EBITDA 16.34
EPS(TTM)2.04
EY3.54%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.04
FCFY3.53%
OCF(TTM)2.91
OCFY5.06%
SpS18.41
BVpS7.35
TBVpS6.62
PEG (NY)N/A
PEG (5Y)1.68
Graham Number18.3619 (-68.15%)
Profitability
Industry RankSector Rank
ROA 16.4%
ROE 28.14%
ROCE 34.67%
ROIC 27.56%
ROICexc 66.14%
ROICexgc 85.44%
OM 14.52%
PM (TTM) 11.23%
GM 24.22%
FCFM 11.07%
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
ROICexc(3y)48.46%
ROICexc(5y)45.93%
ROICexgc(3y)62.9%
ROICexgc(5y)61.44%
ROCE(3y)35.98%
ROCE(5y)33.03%
ROICexgc growth 3Y4.75%
ROICexgc growth 5Y18.9%
ROICexc growth 3Y6.87%
ROICexc growth 5Y18.29%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
F-Score8
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 144.19%
Cap/Sales 4.76%
Interest Coverage 250
Cash Conversion 88.83%
Profit Quality 98.6%
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z 11.32
F-Score8
WACC8.95%
ROIC/WACC3.08
Cap/Depr(3y)112.41%
Cap/Depr(5y)107.09%
Cap/Sales(3y)3.78%
Cap/Sales(5y)3.81%
Profit Quality(3y)90.78%
Profit Quality(5y)99.01%
High Growth Momentum
Growth
EPS 1Y (TTM)21.73%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%2.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%3.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.19%
EBIT growth 3Y12.65%
EBIT growth 5Y14.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.02%
FCF growth 3Y34.78%
FCF growth 5Y13.57%
OCF growth 1Y54.05%
OCF growth 3Y23.73%
OCF growth 5Y9.51%

CORVEL CORP / CRVL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CORVEL CORP (CRVL) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CRVL.


Can you provide the valuation status for CORVEL CORP?

ChartMill assigns a valuation rating of 2 / 10 to CORVEL CORP (CRVL). This can be considered as Overvalued.


How profitable is CORVEL CORP (CRVL) stock?

CORVEL CORP (CRVL) has a profitability rating of 9 / 10.


What are the PE and PB ratios of CORVEL CORP (CRVL) stock?

The Price/Earnings (PE) ratio for CORVEL CORP (CRVL) is 28.26 and the Price/Book (PB) ratio is 7.85.